
|Articles|June 1, 2008
- Volume 0 0
NYCOMED MERGES WITH BRADLEY PHARMACEUTICALS
Advertisement
Nycomed US Inc recently completed its acquisition of Bradley Pharmaceuticals, a company focused on niche therapeutic markets in the United Sates. Nycomed will expand the line of dermatology products currently offered through its PharmaDerm Division. The company also expects that the purchase will provide an enhanced platform for in-licensing and copromotion of dermatology products.
Articles in this issue
almost 18 years ago
can you READ these Rxs?almost 18 years ago
Case Studiesalmost 18 years ago
ASTHMA WATCHalmost 18 years ago
CHOLESTEROL WATCHalmost 18 years ago
ARTHRITIS WATCHalmost 18 years ago
WOMEN'S HEALTH WATCHalmost 18 years ago
DIABETES WATCHalmost 18 years ago
compounding HOTLINEalmost 18 years ago
pharmacy TECHNOLOGY newsalmost 18 years ago
pharmacy TECHNOLOGY productsAdvertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
FAQ: Guidance for Pharmacists, SSRIs Under Scrutiny and Political Debate
2
What Pharmacists Should Know About High-Dose Semaglutide’s Safety Profile
3
Ensitrelvir Demonstrates Significant COVID-19 Post-Exposure Prophylaxis Efficacy in Phase 3 Trial
4
FDA Approves Baxdrostat as First-in-Class Aldosterone Synthase Inhibitor for Hypertension
5



































































































































